How do we Adapt to Continue Making Accurate, Experimental-Based Predictions of Drug Abuse Risks?
DevelRx takes great pleasure to announce that we will be co-hosting a workshop at the 83rd Annual Scientific Virtual Meeting of the College on Problems of Drug Dependence (CPDD) conference, June 19th - 23rd 2021:
“Meeting the Challenge of the Psychedelics and CNS Drugs with Novel Mechanisms – Building on the Foundation of the FDA 2017 Guidance on the Assessment of Abuse Potential”
The workshop will be chaired by Professor David Heal (DevelRx, UK; University of Bath, UK) and Professor Jack Henningfield (Pinney Associates, USA; Johns Hopkins University School of Medicine, USA).
Talks addressing the issues will be given by the eminent scientists: Jack Henningfield, David Heal, Professor Charles France (University of Texas Health Science Center at San Antonio, USA) and Dr Judy Ashworth (Pinney Associates, USA),
This will be a highly interactive forum and is relevant to participants from the pharmaceutical industry, regulatory agencies, healthcare professionals and academia.
https://cpdd.societyconference.com/conf/#sessions/conf10002%20